Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Gastroenterology
»
Gastrointestinal
»
Inflammatory Bowel Disease
12. April 2026
Search
medline.ch
Inflammatory Bowel Disease
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Gastrointestinal
Diarrhea
Inflammatory Bowel Disease
Functional Diseases
Gastroenteritis
Gastrointestinal Hemorrhage
Neoplasms
Peptic Ulcer
Others
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 2865
Articles 1 - 20 / 57297
Assessing the impact of delivery method on severe maternal morbidity among individuals with inflammatory bowel disease: a population-based study.
J Crohns Colitis
Simpson AN, Sutradhar R, Benchimol EI, Chan WC, Porter JM, Moore S, Dossa F, Huang V, Maxwell C, Targownik L, Snelgrove JW, Liu N, Baxter NN.
PMID: 41964942 [PubMed - indexed for MEDLINE]
Correction to:Â DOP055 Efficacy and Safety Up to 3 Years of Risankizumab Maintenance Treatment in Patients With Moderately to Severely Active Ulcerative Colitis: Interim Results from Phase 3 COMMAND Open-Label Extension Study.
J Crohns Colitis
PMID: 41964941 [PubMed - in process]
Surgically Treated Perianal Abscess in Children: Clinical Characteristics and Subsequent Diagnosis of Crohn's Disease.
Eur J Pediatr
Dreznik Y, Sharabi S, Shouval D, Paran M, Kravarusic D.
PMID: 41964806 [PubMed - indexed for MEDLINE]
Psychological help-seeking behaviours amongst those living with Inflammatory Bowel Disease; A cross-sectional, descriptive, correlational study.
PLoS One
Byron C, Cornally N, Burton A, Lehane E.
PMID: 41961753 [PubMed - indexed for MEDLINE]
B cell-driven immune remodeling in inflammatory bowel disease: links to pathogenesis and therapeutic failure.
Inflamm Res
Li G, Cao H, Hong J.
PMID: 41961250 [PubMed - indexed for MEDLINE]
Correction: Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study).
J Gastroenterol
Matsuoka K, Hirai F, Watanabe K, Hokari R, Kobayashi T, Saruta M, Nakase H, Suzuki T, Yamazaki G, Hibi T, Watanabe M, Hisamatsu T.
PMID: 41961124 [PubMed - as supplied by publisher]
Selective Drug-Free Active Surveillance in Ulcerative Colitis: Biomarker-Guided, Patient-Centered Approach.
JGH Open
Nishida T, Osugi N, Amano T, Yoshihara T.
PMID: 41958468 [PubMed]
Perianal fistulising Crohn disease-associated malignancy: a multi-institutional study of histology, clinical features, and outcomes.
Pathology
Navale P, Toro P, Hu S, Wen KW, Liao X, Zhang D, Alpert L, Liu X.
PMID: 41956935 [PubMed - as supplied by publisher]
ACAT1-mediated lactylation reprogramming governs immune-stromal crosstalk in ulcerative colitis.
Int Immunopharmacol
Yan J, Lin S, Chen Z, Zhou S, Zhao Y, Wang W, Wang Z, Feng Y, Luo L.
PMID: 41955702 [PubMed - as supplied by publisher]
Predicting gut metabolites from gut microbiome and their interpretability analysis of IBD prediction based on LIME.
Integr Biol (Camb)
Liu J, Li K, Zhang Y, Huang K, Guan X.
PMID: 41955160 [PubMed - indexed for MEDLINE]
School and School-Related Experiences of Children and Adolescents With Inflammatory Bowel Disease: A Scoping Review.
Child Care Health Dev
Rice J, Wilkinson C.
PMID: 41954331 [PubMed - indexed for MEDLINE]
Association Between Serum PADI-4 Levels and Disease Activity in Ulcerative Colitis Patients.
Gastroenterol Res Pract
, I, Yortanl, Çekiç C.
PMID: 41953069 [PubMed]
Potential for anti‑angiogenic therapy targeting the receptor for advanced glycation end products/VEGF axis in ulcerative colitis (Review).
Mol Med Rep
Xu C, Li Y, Hong Y, Zhou D, He K, Wang L, Hong F.
PMID: 41952489 [PubMed - indexed for MEDLINE]
Why the Assay Matters in Model-Informed Precision Dosing: An Example of Ustekinumab in Crohn's Disease.
Clin Pharmacokinet
Zhang W, Wang Z, Dervieux T, Geukens N, Verstockt B, Ferrante M, Vermeire S, Dreesen E.
PMID: 41951930 [PubMed - as supplied by publisher]
Quantifying artificial sweeteners and emulsifiers in Crohn's disease and its relationship with disease activity: the ENIGMA study - a novel and targeted approach.
Gut
Zhang J, Hu J, Tang X, Ruan Y, Hao F, Zhang W, Trakman G, Hamilton AL, Lin W, Sun Y, Ching JYL, Teh JJ, Kang S, Wilson-O' Brien A, Stanley A, Zhang L, Sung JJY, Yu J, Miao Y, Chan FKL, Morrison M, Kamm M, Ng SC.
PMID: 41951359 [PubMed - as supplied by publisher]
From Intestine to Liver: A Review of the Pathological Mechanisms of Ulcerative Colitis-Induced Secondary Liver Injury and Targeted Therapies with Medicinal.
J Nutr Biochem
Zhou J, Xin X, Wang Y.
PMID: 41951108 [PubMed - as supplied by publisher]
An algorithm-enhanced stool DNA system improves the differential diagnosis of colorectal cancer versus Crohn's disease in high-risk symptomatic patients.
Comput Methods Programs Biomed
Gao L, Guo Z, Wang Z, Wang M.
PMID: 41950614 [PubMed - as supplied by publisher]
One therapy, many targets: redefining ulcerative colitis treatment through fecal microbiota transplantation.
Ther Adv Gastroenterol
Rynikova M, Bojcukova V, Demeckova V.
PMID: 41948520 [PubMed]
Large vessel vasculitis combined with inflammatory bowel disease: epidemiology, shared pathogenesis, and therapeutic advances.
Front Immunol
He M, Yang Y, Hu Y.
PMID: 41948315 [PubMed - indexed for MEDLINE]
Advances in Crohn's Disease: A Comprehensive Review of Pathophysiology, Diagnosis, and Emerging Therapeutics.
JGH Open
An YK, Gilmore R, Radford-Smith G, Begun J.
PMID: 41947907 [PubMed]
Articles 1 - 20 / 57297
Page 1 of 2865
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy